ATCOR MEDICAL INC USA

ATCOR MEDICAL INC USA specializes in the manufacturing of advanced hemodynamic monitoring systems, particularly focused on non-invasive arterial pulse wave analysis technologies. Their core capabilities center on the design, production, and delivery of precision medical instruments used for cardiovascular assessment, including systems that measure aortic stiffness, wave reflection, and central blood pressure. The company demonstrates deep technical expertise in cardiovascular signal processing, waveform analysis algorithms, and FDA-regulated medical device manufacturing under ISO 13485 standards. A key differentiator is their exclusive focus on branded, clinically validated platforms such as the SphygmoCor system, which enables clinicians to perform high-fidelity arterial waveform acquisition and analysis for risk stratification and treatment guidance in hypertension and heart failure. The contractor maintains a consistent relationship with the Department of Veterans Affairs, supplying specialized cardiovascular diagnostic equipment to VA medical centers. Their work supports veteran cardiac care pathways by providing reliable, evidence-based tools for early detection of vascular dysfunction and personalized treatment planning. The nature of these engagements suggests a trusted vendor relationship built on regulatory compliance, clinical utility, and integration with existing VA clinical workflows. ATCOR MEDICAL INC USA operates exclusively within NAICS 339112, which defines the manufacturing of surgical and medical instruments, with a narrow vertical specialization in cardiovascular diagnostic devices. This positions them as a niche supplier in the interventional cardiology and preventive cardiovascular medicine markets, serving hospitals and VA facilities that require high-accuracy, non-invasive hemodynamic assessment tools. As a small business structured as a 2L entity based in Naperville, Illinois, ATCOR MEDICAL INC USA has no federal certifications on record. Their market presence is defined by technical precision and regulatory adherence rather than broad certification portfolios, allowing them to maintain focused production and distribution of specialized medical instrumentation for federal healthcare providers.